The HR increased the most at T 1 (LOC time) compared to the baseline and then showed a decreasing trend, but this was not statistically significant (Fig. 4 b).
← all excerpts
Effective dose of remimazolam co-administered with remifentanil to facilitate I-gel insertion without neuromuscular blocking agents: an up-and-down sequential allocation trial.
1
—
—